Funding and Training

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
A male scientist looks into a microscope while a female scientist looks on.

CGH helps reduce the global burden of cancer by strengthening research capacity through funding and training. Below you will find the most recent funding opportunities that are relevant to our work.

Explore a full listing of NIH funding announcements

 

Funding Opportunities

U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21)

The purpose of the U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer program is to stimulate collaborations in basic, translational, and clinical cancer research between United States (U.S.)-based researchers and Russian researchers. The program promotes collaborative projects in the areas of cancer biology, prevention, early detection, diagnosis, and treatment as well as the physical sciences and engineering in cancer biology, nanotechnology, and radiation exposure epidemiology.

Key Dates:
Application Due Date: November 4, 2016

International Tobacco and Health Research and Capacity Building Program (R01)

The International Tobacco and Health Research and Capacity Building Program aims to encourage trans-disciplinary research on the international tobacco epidemic, and focuses on reducing the global burden of morbidity and mortality caused by tobacco use.

The program is designed to promote international research collaborations between investigators in the U.S. and scientists/institutions in low- and middle-income countries (LMICs) to pursue research on tobacco control and prevention in LMICs.

The program allows investigators in the U.S. and upper-middle-income countries to gain expertise working under LMIC-specific conditions where tobacco consumption poses a public health challenge. It also strengthens the research base of the participating institutions, in particular in the LMICs. To this end, research capacity strengthening in LMICs must be an integrated and significant part of the research application.

Key Dates:
Letter of Intent Deadline: September 13, 2016
Application Due Date: October 13, 2016

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21)

Fogarty International Center, in collaboration with the National Cancer Institute, National Institute of Biomedical Imaging and BioengineeringNational Institute on Deafness and Other Communication DisordersNational Institute of Mental Health, and Office of Behavioral and Social Sciences Research, has developed a new funding opportunity to encourage exploratory/developmental research applications that propose to conduct research to develop or adapt innovative mobile health (mHealth) technology specifically suited for low and middle income countries (LMICs) and determine the health-related outcomes associated with implementation of the technology. Of highest interest are innovative, well-designed multidisciplinary projects that aim to generate generalizable knowledge for the field.

The overall goal of the FOA is to contribute to the evidence base for the use of mobile technology to improve clinical outcomes and public health while building research capacity in LMICs and establishing research networks in this area. Applicants are required to propose partnerships between at least one U.S. institution and one LMIC institution and the proposed research plan should strengthen the mHealth research capabilities at the LMIC institution. 

NCI recognizes the utility of mobile communication technologies: (a) to prevent avoidable cancers by reducing exposure to carcinogenic agents and by promoting healthy life styles; (b) to support early detection, when the opportunities for curing or controlling the cancer are optimal; (c) to facilitate accurate diagnosis and effective treatment planning; (d) to support reliable communications between all members of the care team, including the patient, during treatment; and (e) to offer an unbroken system of support during survivorship and at end-of-life. Specific examples of relevant research objectives include, but are not limited to, the following:

  • Extending mHealth platforms to include point of care technologies;
  • Using mHealth approaches to address issues related to patient abandonment;
  • Integrating personal surveillance data from mobile and wireless devices into e-Health records;
  • Improving patient education and clinical trial recruitment through mobile communication strategies;
  • Bolstering cancer control efforts through mobile applications that prevent smoking, encourage exercise, and promote healthy diets;
  • Utilizing the digital photography and geopositioning capabilities of mobile technologies to aid in the early detection of cancers especially in underserved or remote areas;
  • Developing capacity-building projects internationally that will offer synchronous and asynchronous management, and monitoring, of treatment plans;
  • Creating a communication safety net for cancer survivors that will allow them to thrive after treatment, while adhering to the evolving guidance of a proactive survivorship care plan; and
  • Developing support tools for hospice workers, home care specialists, caregivers, and patients to improve palliation and end-of-life decision making.

Key Dates:
Open Date: July 31, 2016
Application Due Dates: August 31, 2016; August 31, 2017; August 31, 2018

Revision Applications for U.S-South Africa Program for Collaborative Biomedical Research (R01)  Revision Applications for U.S-South Africa Program for Collaborative Biomedical Research (U01)

The National Cancer Institute, in collaboration with the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health, has developed the Revision Applications for U.S-South Africa Program for Collaborative Biomedical Research funding opportunities (R01 and U01) to expand specific activities under the U.S.-South Africa Program for Collaborative Biomedical Research.  The purpose of these opportunities under the revision application is to increase the number of underrepresented scientists engaged in collaborative research activities in the areas of tuberculosis, HIV/AIDS biomedical and behavioral science, and HIV-related co-morbidities, including malignancies.

Key Dates:
Open Date: July 2, 2016
Application Due Date: August 2, 2016

Planning for Regional Centers of Research Excellence in Non-communicable Diseases in Low and Middle Income Countries (P20)

The National Cancer Institute, through its Center for Global Health, seeks to facilitate the planning and design of Regional Centers of Research Excellence (RCRE) for non-communicable disease, including cancer, in low and middle-income countries (LMICs).  Activities in this P20 will be implemented through collaborative partnerships between investigators from institutions in high-income countries or upper- middle-income countries and investigators, research administrators, and other stakeholders from LMICs. The planning efforts must demonstrate an understanding of the region's research capabilities and a commitment to enhance these capabilities with a focus on basic, translational, clinical, and population science research for Non-Communicable Diseases (NCDs).  Research activities undertaken through this initiative should demonstrate that the collaborators can work together to answer NCD questions that are relevant, timely, and important to the concerned region.

The planning efforts to be supported under this FOA should initiate Regional Centers of Research Excellence on NCDs, and demonstrate an ability to undertake high-quality, well-coordinated, regionally-relevant collaborative research on NCDs in LMICs.

Monday, June 13, 2016, NCI hosted a public webinar for investigators interested in applying to the P30 NCD RCRE Program, RFA CA15-007. Download the slides shared during the webinar. This short slide set can be downloaded for clarification on the intent and mechanics of the RFA. Here are some brief instructions to help you register in the NIH eRA Commons, SAM, and DUNS number systems.

For more information, please view our Frequently Asked Questions (FAQ) page.  We will be updating the FAQ site continually, so please check back regularly to view new FAQs.  

Key Dates:
Open Date: September 14, 2015
Application Due Date: August 23, 2016

Emerging Global Leader Award (K43)

The NCI's Center for Global Health (CGH) will support intensive, mentored research career development for early stage investigators committed to a cancer research career. CGH is particularly interested in applications that include well-designed epidemiology studies on common risk factors (social, biological, occupational, environmental) for cancer, clinical and translational research, detection and diagnosis, health surveillance including cancer registry development, knowledge sharing, implementation science, informatics, mHealth, or malignancies associated with chronic infection. The research activities must be specifically focused on the cancer. The career development plan should include training in advanced scientific skills, research methodology, data management and analysis, grant and manuscript writing, and research administration skills that are appropriated for the LMIC. The proposed training and mentoring must be focused on developing independent researchers in the field of cancers in a manner that increases the research capacity at the LMIC institution. Mentors should have a track record of research in cancer.

The National Cancer Institute's Office of HIV and AIDS Malignancy will support intensive, mentored research career development for early stage investigators who plan to commit to a research career in pursuing research in epidemiology, pathogenesis, screening, prevention and management of HIV/AIDS-related cancers.  The career development plan should include training in advanced scientific skills, research methodology, data management and analysis, grant and manuscript writing, and research administration skills that are appropriated for the LMIC.  The research activities must be specifically focused in the context of HIV and must primarily take place in the LMIC. The proposed training and mentoring must be focused on developing independent researchers in the field of HIV/AIDS-related cancers in a manner that increases the research capacity at the LMIC institution. Mentors should have a track record of research in HIV or HIV/AID- related cancers.

Key Dates:
Open Date: November 16, 2015
Application Due Dates: December 14, 2016; and December 14, 2017

Global Non-Communicable Diseases and Injury Across the Lifespan: Exploratory Research (R21)

The National Cancer Institute (NCI) coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients. NCI’s interest in this PAR is in funding exploratory research along the cancer continuum (prevention, detection, diagnosis, treatment and survivorship) including well-designed epidemiology studies on common risk factors (social, biological, occupational, environmental) for cancer, use of mobile technologies such mHealth, cancer health disparities/inequities, cancers associated with chronic infections including malignancies in the context of HIV infection, ecological-niche cancers, cancer surveillance including use of cancer registry data for research, and implementation science approaches that analyze ways to achieve economic efficiencies in the management of cancer and translational research.

Key Dates:
Application Due Date: February 22, 2017

International Research Scientist Development Award (K01)

The NCI's Center for Global Health (CGH) will support intensive, mentored research career development for early stage investigators committed to a cancer research career. CGH is particularly interested in applications that include well-designed epidemiology studies on common risk factors (social, biological, occupational, environmental) for cancer, clinical and translational research, detection and diagnosis, health surveillance including cancer registry development, knowledge sharing, implementation science, informatics, mHealth, or malignancies associated with chronic infection. The research activities must be specifically focused on cancer.

The career development plan should include training in advanced scientific skills, research methodology, data management and analysis, grant and manuscript writing, and research administration skills that are appropriated for the LMIC. The proposed training and mentoring must be focused on developing independent researchers in the field of cancers in a manner that increases the research capacity at the LMIC institution. Mentors should have a track record of research in cancer.

Key Dates:
Open Date: February 2, 2016
Application Due Dates: March 2, 2017; and March 7, 2018

Supplements to Promote Clinical Research Studies on Pediatric Burkitt Lymphoma in Low- and Middle-Income Countries (Admin Supp)

The NCI's Center for Global Health seeks to promote clinical research studies on pediatric Burkitt Lymphoma (BL) in low- and middle-income countries (LMICs). This administrative supplement funding opportunity announcement (FOA) uses the World Bank's definition of LMIC, which provides relevant definitions for low, lower-middle, and upper-middle income countries. Through this FOA, the NCI will provide administrative supplements to selected P30 grants for NCI-designated Cancer Centers. These supplements are expected to augment Cancer Center research by supporting pilot research projects on pediatric BL relevant to specific needs of the respective LMICs. These pilot projects must involve collaborations between Cancer Centers and appropriate institutions in LMICs. The collaborations will leverage the scientific expertise of the Cancer Centers and help develop diagnosis and treatment strategies to alleviate pediatric BL burden in LMICs.

Key Dates:
Application Due Date: Closed

Beginning Investigator Grant for Catalytic Research (BIG Cat)

CRDF Global is accepting Letters of Intent (LOIs) from early career African based investigators working in the field of cancer research for the Beginning Investigator Grant for Catalytic Research (BIG Cat) program, an African Organisation for Research and Training in Cancer (AORTIC) program with support from the U.S. National Institutes of Health’s (NIH) National Cancer Institute (NCI). The primary goals and objectives of the initiative are to support exploratory data collection by African clinicians and scientists engaged in cancer research in Africa, and to encourage research that span the cancer continuum and aimed at forming a basis for reducing the burden of cancer in Africa. Research areas can include descriptive epidemiology, prevention, detection, diagnosis, and treatment including supportive and palliative care and behavioral. 

Key Dates:
Letter of Intent Due Date:
Closed

Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3)

The National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering have developed a funding opportunity to support the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost devices or assays that are clinically comparable to currently used technologies for imaging, in vitro detection/diagnosis, prevention or treatment of cancers in humans living in LMICs.

Key Dates:
Application Due Date:
Closed

For more information on this initiative, please read Technologies for Global Health RFA FAQs.

Turkey-US Collaborative Program for Affordable Medical Technologies 

The National Cancer Institute, through its Center for Global Health, Division of Cancer Control and Population Sciences, Division of Cancer Treatment and Diagnosis, and National Institute of Biomedical Imaging and Bioengineering, invites applications from research partnerships formed between scientists from U.S. and Turkey to accelerate the development of appropriate affordable diagnostic and therapeutic technologies, which address medical needs in low-middle resource settings. The collaborations should be aimed at developing medical technologies that can significantly impact underserved populations within the United States and/or Turkey, and potentially populations in Low and Middle Income Countries, particularly in Africa, the Middle East,  Eastern Europe, and Latin America. 

Key Dates:
Application Due Date: Closed

Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries (Admin Supp)

The National Cancer Institute (NCI), through its Center for Global Health (CGH), seeks to promote cancer prevention and control (CPC) research in low- and middle-income countries (LMICs) through collaborations and research partnerships between the NCI-designated cancer centers and partner institutions in LMICs. Through this funding opportunity announcement (FOA), the NCI will provide administrative supplement awards to currently-funded P30 NCI-designated cancer center grantees to support pilot research plans that focus on cancer prevention and control. These supplements are designed to stimulate and strengthen CPC twinning programs between researchers at the NCI-designated cancer centers and institutions in LMICs. It is anticipated that outcomes of this supplement will include collaborative research grants between investigators at the NCI-designated cancer centers and LMIC institutions.

Key Dates:
Application Due Date: Closed

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)

The National Cancer Institute, Division of Cancer Treatment and Diagnosis has developed a funding opportunity to encourage applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for pre-clinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem. 

Key Dates:
Application Due Date:
Closed

Funding Opportunity Announcement for Cancer Research in the Caribbean

CGH and the Caribbean Public Health Agency (CARPHA) have developed a co-funded opportunity to support the research of cancers that are of a significant burden within a Caribbean population or community, a Caribbean country, or throughout the Caribbean.

Key Dates:
Application Due Date: Closed

 

Training Opportunities

  • CGH Fellowship Program

    The Center for Global Health Fellowship Program provides recent college graduates who are planning to apply to graduate or professional (public health/research/medical/dental/nursing/pharmacy) school an opportunity to spend up to two years performing full-time work in the global cancer field at NCI. Fellows work with NCI staff to develop and implement projects that support strengthening of cancer research and cancer control globally. CGH is particularly interested in applicants who have either volunteered or worked in a low- or middle-income country or with disadvantaged populations in high-income countries. 

  • CGH Short Term Scientist Exchange Program (STSEP)

    The STSEP promotes collaborative research between established U.S. and foreign scientists from low- and middle-income countries (LMICs) and upper-middle income countries by supporting, in part, exchange visits of cancer researchers between U.S. and foreign laboratories that are six months or less.

  • NCI Summer Curriculum in Cancer Prevention Program

    This program offers two short-term cancer prevention training courses in Rockville, MD to international scientists and healthcare professionals from LMICs and the All-Ireland Cancer Consortium (AICC).